INVESTORS

Pioneering Groundbreaking Solutions for Brain Diseases

EVENTS

View All

12th Alzheimer's & Parkinson's Drug Development Summit

Invited to speak at the Alzheimer's & Parkinson's Drug Development Summit in Boston

View Detail

APR 23-25, 2024

View Detail

APR 23-25, 2024

NEWSROOM

View All

PUBLICATION

June 28, 2024

Structure-guided Engineering of Thermodynamically Enhanced SaCas9 for Improved Gene Suppression

MAR 28, 2023

Cerebrospinal fluid-philic and biocompatibility-enhanced soft cranial window for long-term in vivo brain imaging

MAR 08, 2022

Deep brain stimulation of the anterior nuclei of the thalamus can alleviate seizure severity and induce hippocampal GABAergic neuronal changes in a pilocarpine-induced epileptic mouse brain

SEP 08, 2020

Infection of brain organoids and 2D cortical neurons with SARS-CoV-2 pseudovirus

AUG 05, 2020

In vitro modeling for inherited neurological diseases using induced pluripotent stem cells: from 2D to organoid

IMNEWRUN’s mission is to create transformative solutions for patients with brain diseases. Through strategic partnerships with the nation’s leading universities, pharmaceutical companies, and investors, we aim to build an institutional platform to catalyze innovation in neuro-biotechnology.